Tag: Eastern District of Pennsylvania

Displaying 1 - 20 of 21 results.

Brief of the Federal Trade Commission as Amicus Curiae before the United States District Court for the Eastern District of Pennsylvania, addressing whether a branded company's commitment not to launch an authorized generic in competition with a generic company can constitute a...
Brief of the Federal Trade Commission as amicus curiae before the United States District Court for the Eastern District of Pennsylvania, addressing the question of whether reformulations of a branded company’s products that offer patients little or no therapeutic...
On 2/13/2008, the Commission filed a complaint in federal district court charging Cephalon, Inc. with preventing competition to its branded drug Provigil. The conduct under challenge includes paying four firms to refrain from selling generic versions of Provigil until 2012. Cephalon’...
Memorandum of the Federal Trade Commission, as amicus curiae, addressing the propriety of de-listing a patent from FDA's "Orange Book," as a remedy for patent invalidity. The brief explains that improperly-maintained Orange Book listings may serve as a barrier to competition, and...

Pages